Hispidulin Attenuates Cardiac Hypertrophy by Improving Mitochondrial Dysfunction

被引:10
|
作者
Wang, Yan [1 ,2 ,3 ,4 ]
Xie, Zengshuo [1 ,3 ,4 ]
Jiang, Nan [5 ]
Wu, Zexuan [1 ,3 ]
Xue, Ruicong [1 ,3 ]
Dong, Bin [1 ,3 ]
Fan, Wendong [1 ,3 ]
Dai, Gang [1 ,3 ]
Chen, Chen [1 ,3 ]
Li, Jiayong [1 ,3 ]
Chen, Hao [1 ,3 ]
Ye, Zi [6 ]
Fang, Rong [1 ,3 ]
Choy, Manting [1 ,3 ]
Zhao, Jingjing [1 ,3 ]
Dong, Yugang [1 ,3 ,4 ]
Liu, Chen [1 ,3 ,4 ]
机构
[1] Sun Yat Sen Univ, Dept Cardiol, Affiliated Hosp 1, Guangzhou, Peoples R China
[2] Second Peoples Hosp Guangdong Prov, Dept Cardiol, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, NHC Key Lab Assisted Circulat, Guangzhou, Peoples R China
[4] Natl Guangdong Joint Engn Lab Diag & Treatment Va, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Dept Anesthesiol, Affiliated Hosp 1, Guangzhou, Peoples R China
[6] Univ New South Wales, St Vincent Clin Sch, Fac Med, Sydney, NSW, Australia
来源
关键词
cardiac hypertrophy; hispidulin; mitochondrial dysfunction; heart failure; oxidative stress; ENERGY-METABOLISM; HEART-FAILURE; MOUSE HEARTS; PPAR-ALPHA; SIRT1; ACTIVATION; PATHWAYS; FISSION; DISEASE; GROWTH;
D O I
10.3389/fcvm.2020.582890
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac hypertrophy is a pathophysiological response to harmful stimuli. The continued presence of cardiac hypertrophy will ultimately develop into heart failure. The mitochondrion is the primary organelle of energy production, and its dysfunction plays a crucial role in the progressive development of heart failure from cardiac hypertrophy. Hispidulin, a natural flavonoid, has been substantiated to improve energy metabolism and inhibit oxidative stress. However, how hispidulin regulates cardiac hypertrophy and its underlying mechanism remains unknown. We found that hispidulin significantly inhibited pressure overload-induced cardiac hypertrophy and improved cardiac function in vivo and blocked phenylephrine (PE)-induced cardiomyocyte hypertrophy in vitro. We further proved that hispidulin remarkably improved mitochondrial function, manifested by increased electron transport chain (ETC) subunits expression, elevated ATP production, increased oxygen consumption rates (OCR), normalized mitochondrial morphology, and reduced oxidative stress. Furthermore, we discovered that Sirt1, a well-recognized regulator of mitochondrial function, might be a target of hispidulin, as evidenced by its upregulation after hispidulin treatment. Cotreatment with EX527 (a Sirt1-specific inhibitor) and hispidulin nearly completely abolished the antihypertrophic and protective effects of hispidulin on mitochondrial function, providing further evidence that Sirt1 could be the pivotal downstream effector of hispidulin in regulating cardiac hypertrophy.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Mitochondrial Dysfunction in Arrhythmia and Cardiac Hypertrophy
    Wang, Xiaomei
    Yu, Qianxue
    Liao, Xuemei
    Fan, Mengying
    Liu, Xibin
    Liu, Qian
    Wang, Manru
    Wu, Xinyu
    Huang, Chun-Kai
    Tan, Rubin
    Yuan, Jinxiang
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (12)
  • [2] MITOCHONDRIAL DYSFUNCTION - IMPLICATION AND IMPORTANCE IN CARDIAC HYPERTROPHY
    Kar, Dipak
    Bandyopadhyay, Arun
    JOURNAL OF HYPERTENSION, 2018, 36 : E90 - E90
  • [3] TRPC3 deficiency attenuates high salt-induced cardiac hypertrophy by alleviating cardiac mitochondrial dysfunction
    Ma, Tianyi
    Lin, Shaoyang
    Wang, Bin
    Wang, Qianran
    Xia, Weijie
    Zhang, Hexuan
    Cui, Yuanting
    He, Chengkang
    Wu, Hao
    Sun, Fang
    Zhao, Zhigang
    Gao, Peng
    Zhu, Zhiming
    Liu, Daoyan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 519 (04) : 674 - 681
  • [4] Nitric oxide and mitochondrial dysfunction in cardiac hypertrophy.
    Dai, LJ
    Brookes, PS
    Zhang, JX
    Darley-Usmar, VM
    Anderson, PG
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (06) : A153 - A153
  • [5] Evidence of persisting mitochondrial dysfunction in a model of reversible cardiac hypertrophy
    Di Maria, Carla A.
    McKitrick, Douglas J.
    Holobotovskyy, Vasyl
    Arnolda, Leonard
    Bogoyevitch, Marie A.
    Arthur, Peter G.
    Hool, Livia C.
    CIRCULATION RESEARCH, 2006, 99 (05) : E40 - E40
  • [6] Antiandrogenic Therapy With Finasteride Attenuates Cardiac Hypertrophy and Left Ventricular Dysfunction
    Zwadlo, Carolin
    Schmidtmann, Elisa
    Szaroszyk, Malgorzata
    Kattih, Badder
    Froese, Natali
    Hinz, Hebke
    Schmitto, Jan Dieter
    Widder, Julian
    Batkai, Sandor
    Baehre, Heike
    Kaever, Volkhard
    Thum, Thomas
    Bauersachs, Johann
    Heineke, Joerg
    CIRCULATION, 2015, 131 (12) : 1071 - 1081
  • [7] Quercetin Attenuates Cardiac Hypertrophy by Inhibiting Mitochondrial Dysfunction Through SIRT3/PARP-1 Pathway
    Chen, Wen-Jing
    Cheng, Yan
    Li, Wen
    Dong, Xiao-Kang
    Wei, Jian-liang
    Yang, Chuan-Hua
    Jiang, Yue-Hua
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] Oroxylin A prevents cardiac hypertrophy and dysfunction as a modulator of mitochondrial protein acetylation
    Aguilar-Saenz, Alejandro
    Trevino-Saldana, Niria
    Oropeza-Almazan, Yuriana
    Garcia-Rivas, Gerardo
    FASEB JOURNAL, 2018, 32 (01):
  • [9] Investigation of the molecular mechanisms underlying cardiac hypertrophy in the presence of mitochondrial dysfunction
    Gallo, Giovanna
    Marchitti, Simona
    Forte, Maurizio
    Cotugno, Maria
    Bianchi, Franca
    Stanzione, Rosita
    Tocci, Giuliano
    Volpe, Massimo
    Rubattu, Speranza
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0B) : B2 - B2
  • [10] Skeletal muscle mitochondrial complex I dysfunction in cardiac hypertrophy and failure
    Wust, Rob C. I.
    Stones, Rachel
    White, Ed
    Boyle, John P.
    Peers, Chris
    Rossiter, Harry B.
    FASEB JOURNAL, 2011, 25